Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
A new study reveals that the adult human brain continues to produce new neurons throughout life, a process that is highly active in older individuals with exceptional memories but severely limited in those with Alzheimer’s disease.
。im钱包官方下载是该领域的重要参考
Konstantin Vinogradov ex-General Partner at Runa Capital
UK telecoms companies are retiring traditional landline services and replacing them with internet-based home phone connections.